164 related articles for article (PubMed ID: 38308276)
21. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs.
Neri F; Krepelova A; Incarnato D; Maldotti M; Parlato C; Galvagni F; Matarese F; Stunnenberg HG; Oliviero S
Cell; 2013 Sep; 155(1):121-34. PubMed ID: 24074865
[TBL] [Abstract][Full Text] [Related]
22. Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma.
Choi JI; Cho EH; Kim SB; Kim R; Kwon J; Park M; Shin HJ; Ryu HS; Park SH; Lee KH
Ann Hepatobiliary Pancreat Surg; 2017 Nov; 21(4):181-187. PubMed ID: 29264579
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic upregulation of Bak by ZBP-89 inhibits the growth of hepatocellular carcinoma.
Ye CG; Chen GG; Ho RLK; Merchant JL; He ML; Lai PBS
Biochim Biophys Acta; 2013 Dec; 1833(12):2970-2979. PubMed ID: 23954442
[TBL] [Abstract][Full Text] [Related]
24. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
25. Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1.
Wu WR; Sun H; Zhang R; Yu XH; Shi XD; Zhu MS; Zeng H; Yan LX; Xu LB; Liu C
Oncotarget; 2016 Apr; 7(14):18684-93. PubMed ID: 26919246
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of sevoflurane in HCC cell line is mediated by miR-29a-induced suppression of Dnmt3a.
Song G; Tian L; Cheng Y; Liu J; Wang K; Li S; Li T
J Cell Biochem; 2019 Oct; 120(10):18152-18161. PubMed ID: 31190353
[TBL] [Abstract][Full Text] [Related]
27. Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer.
Zamani M; Sadeghizadeh M; Behmanesh M; Najafi F
Phytomedicine; 2015 Sep; 22(10):961-7. PubMed ID: 26321746
[TBL] [Abstract][Full Text] [Related]
28. Does mouse embryo primordial germ cell activation start before implantation as suggested by single-cell transcriptomics dynamics?
Gerovska D; Araúzo-Bravo MJ
Mol Hum Reprod; 2016 Mar; 22(3):208-25. PubMed ID: 26740066
[TBL] [Abstract][Full Text] [Related]
29. The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma.
Zhuo H; Tang J; Lin Z; Jiang R; Zhang X; Ji J; Wang P; Sun B
Mol Carcinog; 2016 Feb; 55(2):209-19. PubMed ID: 25641194
[TBL] [Abstract][Full Text] [Related]
30. DNMT3L interacts with transcription factors to target DNMT3L/DNMT3B to specific DNA sequences: role of the DNMT3L/DNMT3B/p65-NFκB complex in the (de-)methylation of TRAF1.
Pacaud R; Sery Q; Oliver L; Vallette FM; Tost J; Cartron PF
Biochimie; 2014 Sep; 104():36-49. PubMed ID: 24952347
[TBL] [Abstract][Full Text] [Related]
31. The CpG island encompassing the promoter and first exon of human DNMT3L gene is a PcG/TrX response element (PRE).
Basu A; Dasari V; Mishra RK; Khosla S
PLoS One; 2014; 9(4):e93561. PubMed ID: 24743422
[TBL] [Abstract][Full Text] [Related]
32. DNA methylation plays an important role in promoter choice and protein production at the mouse Dnmt3L locus.
O'Doherty AM; Rutledge CE; Sato S; Thakur A; Lees-Murdock DJ; Hata K; Walsh CP
Dev Biol; 2011 Aug; 356(2):411-20. PubMed ID: 21645502
[TBL] [Abstract][Full Text] [Related]
33. The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.
Lv Z; Zou H; Peng K; Wang J; Ding Y; Li Y; Ren X; Wang F; Chang R; Liang L; Ding Y
PLoS One; 2013; 8(10):e77473. PubMed ID: 24147003
[TBL] [Abstract][Full Text] [Related]
34. Promoter DNA methylation of CDO1 gene and its clinical significance in esophageal squamous cell carcinoma.
Ushiku H; Yamashita K; Katoh H; Ema A; Minatani N; Kikuchi M; Kojo K; Yokoi K; Tanaka T; Nishizawa N; Ishii S; Hosoda K; Moriya H; Mieno H; Katada N; Kikuchi S; Watanabe M
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 27629777
[TBL] [Abstract][Full Text] [Related]
35. [BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].
He JY; Liu QY; Wei L; Liu ZJ; Huang Y; Yu XQ; Li B; Qin Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):1-7. PubMed ID: 29737080
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.
Revill K; Wang T; Lachenmayer A; Kojima K; Harrington A; Li J; Hoshida Y; Llovet JM; Powers S
Gastroenterology; 2013 Dec; 145(6):1424-35.e1-25. PubMed ID: 24012984
[TBL] [Abstract][Full Text] [Related]
37. TNF-α/NF-κB signaling epigenetically represses PSD4 transcription to promote alcohol-related hepatocellular carcinoma progression.
Shi J; Song S; Li S; Zhang K; Lan Y; Li Y
Cancer Med; 2021 May; 10(10):3346-3357. PubMed ID: 33932127
[TBL] [Abstract][Full Text] [Related]
38. SALL3 interacts with DNMT3A and shows the ability to inhibit CpG island methylation in hepatocellular carcinoma.
Shikauchi Y; Saiura A; Kubo T; Niwa Y; Yamamoto J; Murase Y; Yoshikawa H
Mol Cell Biol; 2009 Apr; 29(7):1944-58. PubMed ID: 19139273
[TBL] [Abstract][Full Text] [Related]
39. DNMT3L promotes neural differentiation by enhancing STAT1 and STAT3 phosphorylation independent of DNA methylation.
Qin L; Qiao C; Sheen V; Wang Y; Lu J
Prog Neurobiol; 2021 Jun; 201():102028. PubMed ID: 33636226
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
